Vietnam Heart Institute doctors evaluate a case before intervention. (Photo courtesy of the company)The AFCC2023, themed "Cardiology at the Crossroads: Challenges andOpportunities", is expected to welcome over 2,000 local and internationalparticipants, including 300 leading cardiovascular experts as guest speakers.
The event, hosted by the Vietnam National Heart Association, will focus oncardiovascular disease management in the context of multiple co-morbidities,newly advanced interventions and technology, artificial intelligence,telemedicine, the limited resources of ASEAN and collaboration with otherdeveloped foreign partners and countries.
This is an important event for Vietnam's cardiovascular industry, and also agood opportunity for doctors in Vietnam and in the region to exchange andupdate knowledge and professional skills.
The congress is also an opportunity to spread health messages to the public inthe fight against increasing cardiovascular diseases in Vietnam, with theultimate goal of improving the quality of cardiovascular health care forVietnamese people.
According to the 2022 Global Burden of Disease report, cardiovascular diseasehas become the leading cause of death worldwide. Each year, it claims 19.5million lives, accounting for one-third of deaths from all causes.
A worrying reality is that the incidence and mortality from cardiovasculardisease is increasing rapidly in low- and lower-middle-income countries(accounting for 75% of total deaths), including ASEAN countries.
According to data from the World Heart Federation, it is estimated that eachyear in the entire ASEAN region, about 4 million people die from cardiovasculardisease.
In Vietnam alone, statistics from the Ministry of Health show that about200,000 people die from cardiovascular disease every year, accounting for 33% ofdeaths. The burden of disease and treatment costs has also increasedsignificantly.
Vietnam is also a country with a high rate of hypertension, one in four adultshas high blood pressure. Meanwhile, high blood pressure increases the risk ofdeath from stroke by four times and the risk of death from cardiovasculardisease by three times compared to people without the disease./.
VNA
